Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 16409-34-0
2. Glycodeoxycholic Acid Sodium Salt
3. 6w76v75mt1
4. Glycodeoxycholic Acid, Sodium Salt
5. Sodium N-((3alpha,5beta,12alpha)-3,12-dihydroxy-24-oxocholan-24-yl)aminoacetate
6. Sodium Glycyldeoxycholate
7. Glycodeoxycholate Sodium
8. Glycodeoxycholate (sodium)
9. Unii-6w76v75mt1
10. Einecs 240-455-4
11. Mfcd00036742
12. Glycodeoxycholic Acid Sodium
13. Chebi:87819
14. Ex-a3817
15. Hy-n1427
16. Sodium N-(3,12-dihydroxy-24-oxocholan-24-yl)glycinate
17. Akos024386292
18. As-73534
19. J286.892j
20. Cs-0016856
21. D78059
22. G-5430
23. Q27159959
24. 5beta-cholanic Acid-3alpha,12alpha-diol N-(carboxymethyl)-amide
25. Sodium N-(3alpha,12alpha-dihydroxy-5beta-cholan-24-oyl)glycinate
26. Sodium [(3alpha,12alpha-dihydroxy-24-oxo-5beta-cholan-24-yl)amino]acetate
27. Glycine, N-((3alpha,5beta,12alpha)-3,12-dihydroxy-24-oxocholan-24-yl)-, Monosodium Salt
28. Glycine, N-(3.alpha.,12.alpha.-dihydroxy-5.beta.-cholan-24-oyl)-, Monosodium Salt
29. N-((3alpha,5beta,12alpha)-3,12-dihydroxy-24-oxocholan-24-yl)aminoacetate
30. N-(2-oxo-2-(sodiooxy)ethyl)-3.alpha.,12.alpha.-dihydroxy-5.beta.-cholane-24-amide
31. N-(3.alpha.,12.alpha.-dihydroxy-24-oxo-5.beta.-cholan-24-yl)glycine Sodium Salt
32. (3.alpha.,12.alpha.-dihydroxy-24-oxo-5.beta.-cholan-24-ylamino)acetic Acid Sodium Salt
33. 2-((4r)-4-((1s,2s,11s,16s,5r,7r,10r,14r,15r)-5,16-dihydroxy-2,15-dimethyltetra Cyclo(8.7.0.0(2,7).0(11,15))heptadec-14-yl)pentanoylamino)acetic Acid, Sodium Salt
34. 3.alpha.,12.alpha.-dihydroxy-24-(((sodiooxycarbonyl)methyl)amino)-5.beta.-cholan-24-one
35. Glycine, N-((3.alpha.,5.beta.,12.alpha.)-3,12-dihydroxy-24-oxocholan-24-yl)-, Monosodium Salt
36. Glycine, N-((3.alpha.,5.beta.,12.alpha.)-3,12-dihydroxy-24-oxocholan-24-yl)-, Sodium Salt (1:1)
37. Glycine, N-[(3??,5??,12??)-3,12-dihydroxy-24-oxocholan-24-yl]-, Sodium Salt (1:1)
38. Sodium (((3.alpha.,5.beta.,12.alpha.,20r)-3,12-dihydroxy-24-oxocholan-24-yl)amino)acetate
39. Sodium 2-(((4r)-4-((3r,5r,8r,9s,10s,12s,13r,14s,17r)-3,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta(a)phenanthren-17-yl)pentanoyl)amino)acetate
40. Sodium 2-[(4r)-4-[(1r,3as,3br,5ar,7r,9as,9bs,11s,11ar)-7,11-dihydroxy-9a,11a-dimethyl-hexadecahydro-1h-cyclopenta[a]phenanthren-1-yl]pentanamido]acetate
41. Sodium;2-[[(4r)-4-[(3r,5r,8r,9s,10s,12s,13r,14s,17r)-3,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]acetate
| Molecular Weight | 471.6 g/mol |
|---|---|
| Molecular Formula | C26H42NNaO5 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 6 |
| Exact Mass | 471.29606772 g/mol |
| Monoisotopic Mass | 471.29606772 g/mol |
| Topological Polar Surface Area | 110 Ų |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 734 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 10 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
99
PharmaCompass offers a list of Sodium Glycodeoxycholate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sodium Glycodeoxycholate manufacturer or Sodium Glycodeoxycholate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sodium Glycodeoxycholate manufacturer or Sodium Glycodeoxycholate supplier.
PharmaCompass also assists you with knowing the Sodium Glycodeoxycholate API Price utilized in the formulation of products. Sodium Glycodeoxycholate API Price is not always fixed or binding as the Sodium Glycodeoxycholate Price is obtained through a variety of data sources. The Sodium Glycodeoxycholate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Sodium Glycodeoxycholate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sodium Glycodeoxycholate, including repackagers and relabelers. The FDA regulates Sodium Glycodeoxycholate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sodium Glycodeoxycholate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sodium Glycodeoxycholate supplier is an individual or a company that provides Sodium Glycodeoxycholate active pharmaceutical ingredient (API) or Sodium Glycodeoxycholate finished formulations upon request. The Sodium Glycodeoxycholate suppliers may include Sodium Glycodeoxycholate API manufacturers, exporters, distributors and traders.
Sodium Glycodeoxycholate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sodium Glycodeoxycholate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sodium Glycodeoxycholate GMP manufacturer or Sodium Glycodeoxycholate GMP API supplier for your needs.
A Sodium Glycodeoxycholate CoA (Certificate of Analysis) is a formal document that attests to Sodium Glycodeoxycholate's compliance with Sodium Glycodeoxycholate specifications and serves as a tool for batch-level quality control.
Sodium Glycodeoxycholate CoA mostly includes findings from lab analyses of a specific batch. For each Sodium Glycodeoxycholate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sodium Glycodeoxycholate may be tested according to a variety of international standards, such as European Pharmacopoeia (Sodium Glycodeoxycholate EP), Sodium Glycodeoxycholate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sodium Glycodeoxycholate USP).
